Multiple levels of posttranscriptional regulation of influenza virus gene expression

Seminars in Virology

Volumn 8, Issue 4, 1998, Pages 335-342

  Ortín, Juan ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Alternative splicing; Host cell shut off; Nucleo cytoplasmic transport; Translation initiation

Indexed keywords

RIBONUCLEOPROTEIN; VIRUS RNA;

GENE EXPRESSION REGULATION; INFLUENZA VIRUS; REVIEW; RNA SPLICING; RNA TRANSPORT; VIRUS GENE; VIRUS GENOME; VIRUS TRANSCRIPTION;

EID: 0031956578     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1997.0136     Document Type: Article

References (79)

1. Lamb R. A. The genes and proteins of influenza viruses. The Influenza Viruses. 1989;Plenum, New York. p. 1-87.
2. Krug R. M., Alonso-Kaplen F. V., Julkunen I., Katze M. G. Expression and replication of the influenza virus genome. Krug R. M. The Influenza Viruses. 1989;89-152 Plenum, New York.
3. Lamb R., Horvath C. Diversity of coding strategies in influenza viruses. Trends Genet. 7:1991;261-266.
4. Krug R. M. The regulation of export of mRNA from nucleus to cytoplasm. Curr. Opin. Cell. Biol. 5:1993;944-949.
5. Katze M. G. The war against the interferon-induced dsRNA activated protein kinase: Can viruses win. J. Interferon Res. 12:1992;241-248.
6. Katze, M. G. 1996, Translational control in cells infected with Influenza virus and Reovirus, In, Translational Control, J. W. B. HersheyM. B. MathewsN. Sonenberg, 608, 630, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
7. Krug R. M., St. Angelo C., Broni B., Shapiro G. Transcription and replication of influenza virion RNA in the nucleus of infected cells. Cold Spring Harbor Symp. Quant. Biol. 52:1987;353-358.
8. Hay A. J. Characterization of influenza virus RNA complete transcripts. Virology. 116:1982;517-522.
9. Krug R. M., Broni B. A., Bouloy M. Are the 5′-ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs. Cell. 18:1979;329-334.
10. Shaw M. W., Lamb R. A. A specific sub-set of host-cell mRNAs prime influenza virus mRNA synthesis. Virus Res. 1:1984;455-467.
11. Albó C., Martín J., Portela A. The 5′ ends of Thogoto virus (Orthomyxoviridae) mRNAs are homogeneous in both length and sequence. J. Virol. 70:1996;9013-9017.
12. Lamb R. A., Choppin P. W. Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc. Natl. Acad. Sci. USA. 76:1979;4908-4912.
13. Lamb R. A., Lai C. J. Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell. 21:1980;475-485.
14. Inglis S. C., Barret T., Brown C. M., Almond J. W. The smallest genome RNA segment of influenza virus contains two genes that may overlap. Proc. Natl. Acad. Sci. USA. 76:1979;3790-3794.
15. Briedis D. J., Lamb R. A., Chopin P. W. Influenza B virus RNA segment 8 codes for two nonstructural proteins. Virology. 111:1981;417-425.
16. Briedis D. J., Lamb R. A. Influenza B virus genome: Sequences and structural organization of RNA segment 8 and the mRNAs coding for the NS1 and NS2 proteins. J. Virol. 42:1982;186-193.
17. Nakada S., Graves P. N., Palese P. The influenza C virus NS gene: Evidence for a spliced mRNA and a second NS gene product (NS2 protein). Virus Res. 4:1986;263-273.
18. Lamb R. A., Lai C. J., Choppin P. W. Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: Colinear and interrupted mRNAs code for overlapping proteins. Proc. Natl. Acad. Sci. USA. 78:1981;4170-4174.
19. Yamashita M., Krystal M., Palese P. Evidence that the matrix protein of influenza C virus is coded for by a spliced mRNA. J. Virol. 62:1988;3348-3355.
20. Hongo S., Sugawara K., Nishimura H., Muraki Y., Kitame F., Nakamura K. Identification of a second protein encoded by influenza C virus RNA segment 6. J. Gen. Virol. 75:1994;3503-3510.
21. Hongo S., Sugawara K., Muraki Y., Kitame F., Nakamura K. Characterization of a second protein (CM2) encoded by RNA segment 6 of influenza C virus. J. Virol. 71:1997;2786-2792.
22. Plotch S. J., Krug R. M. In vitro splicing of influenza viral NS1 mRNA and NS1-beta-globin chimeras: Possible mechanisms for the control of viral mRNA splicing. Proc. Natl. Acad. Sci. USA. 83:1986;5444-5448.
23. Nemeroff M. E., Utans U., Kramer A., Krug R. M. Identification of cis-acting intron and exon regions in influenza virus NS1 mRNA that inhibit splicing and cause the formation of aberrantly sedimenting presplicing complexes. Mol. Cell. Biol. 12:1992;962-970.
24. Agris C. H., Nemeroff M. E., Krug R. M. A block in mammalian splicing occurring after formation of large complexes containing U1, U2, U4, U5, and U6 small nuclear ribonucleoproteins. Mol. Cell. Biol. 9:1989;259-267.
25. Inglis S. C., Brown C. M. Differences in the control of virus mRNA splicing during permissive or abortive infection with influenza A (fowl plague) virus. J. Gen. Virol. 65:1984;153-164.
26. Smith D. B., Inglis S. C. Regulated production of an influenza virus spliced mRNA mediated by virus-specific products. EMBO J. 4:1985;2313-2319.
27. Lamb R. A., Lai C. J. Expression of unspliced NS1 mRNA, spliced NS2 mRNA, and a spliced chimera mRNA from cloned influenza virus NS DNA in an SV40 vector. Virology. 135:1984;139-147.
28. Fortes P., Beloso A., Ortin J. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J. 13:1994;704-712.
29. Alonso C. F., Nemeroff M. E., Qiu Y., Krug R. M. Nucleocytoplasmic transport: The influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA. Genes Dev. 6:1992;255-267.
30. Lu Y., Qian X. Y., Krug R. M. The influenza virus NS1 protein: A novel inhibitor of pre-mRNA splicing. Genes Dev. 8:1994;1817-1828.
31. Qiu Y., Nemeroff M., Krug R. M. The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. RNA. 1:1995;304-316.
32. Ge H., Manley J. L. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell. 62:1990;25-34.
33. Kreiner A. R., Conway G. C., Kozak D. The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites. Cell. 62:1990;35-42.
34. Zahler A. M., Neugebauer K. M., Lane W. S., Roth M. B. Distinct functions os SR proteins in alternative pre-mRNA splicing. Science. 260:1993;219-222.
35. Mermoud J. E., Cohen P. T., Lamond A. I. Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing. Nucleic Acids Res. 20:1992;5263-5269.
36. Mermoud J. E., Cohen P. T., Lamond A. I. Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. EMBO J. 13:1994;5679-5688.
37. Fortes P., Lamond A. I., Ortín J. Influenza virus NS1 protein alters the subnuclear localization of cellular splicing components. J. Gen. Virol. 76:1995;1001-1007.
38. Lamb R. A., Lai C.-J. Spliced and unspliced messenger RNAs synthesized from cloned influenza virus M DNA in an SV40 vector: Expression of the influenza virus membrane protein (M1). Virology. 123:1982;237-256.
39. Shih S. R., Nemeroff M. E., Krug R. M. The choice of alternative 5′ splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex. Proc. Natl. Acad. Sci. USA. 92:1995;6324-6328.
40. Valcárcel J., Fortes P., Ortin J. Splicing of influenza virus matrix protein mRNA expressed from a simian virus 40 recombinant. J. Gen. Virol. 74:1993;1317-1326.
41. Shih S. R., Krug R. M. Novel exploitation of a nuclear function by influenza virus: The cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells. EMBO J. 15:1996;5415-5427.
42. Valcárcel J., Portela A., Ortín J. Regulated M1 mRNA splicing in influenza virus-infected cells. J. Gen. Virol. 72:1991;1301-1308.
43. Katze M. G., Krug R. M. Metabolism and expression of RNA polymerase II transcripts in influenza virus-infected cells. Mol. Cell. Biol. 4:1984;2198-2206.
44. Vogel U., Kunerl M., Scholtissek C. Influenza A virus late mRNAs are specifically retained in the nucleus in the presence of a methyltransferase or a protein kinase inhibitor. Virology. 198:1994;227-233.
45. Qiu Y., Krug R. M. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J. Virol. 68:1994;2425-2432.
46. Qian X. Y., Chien C. Y., Lu Y., Montelione G. T., Krug R. M. An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. RNA. 1:1995;948-956.
47. Norton G. P., Tanaka T., Tobita K., Nakada S., Buonagurio D. A., Greenspan D., Krystal M., Palese P. Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides. Virology. 156:1987;204-213.
48. Katze M. G., Detjen B. M., Safer B., Krug R. M. Translational control by influenza virus: Suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs. Mol. Cell. Biol. 6:1986;1741-1750.
49. Katze M. G., Tomita J., Black T., Krug R. M., Safer B., Hovanessian A. Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase. J. Virol. 62:1988;3710-3717.
50. Lee T. G., Tomita J., Hovanessian A. G., Katze M. G. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc. Natl. Acad. Sci. USA. 87:1990;6208-6212.
51. Lee T. G., Tang N., Thompson S., Miller J., Katze M. G. The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol. Cell. Biol. 14:1994;2331-2342.
52. Gale M. J., Tan S. L., Wambach M., Katze M. G. Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and vaccinia virus K3L is mediated by unique domains: Implications for kinase regulation. Mol. Cell. Biol. 16:1996;4172-4181.
53. Polyak S. J., Tang N., Wambach M., Barber G. N., Katze M. G. The P58 cellular inhibitor complexes with the interferon-induced, double-stranded RNA-dependent protein kinase, PKR, to regulate its autophosphorylation and activity. J. Biol. Chem. 271:1996;1702-1707.
54. Inglis S. C. Inhibition of host protein synthesis and degradation of cellular mRNAs during infection by influenza and Herpes simplex virus. Mol. Cell. Biol. 2:1982;1644-1648.
55. Beloso A., Martínez C., Valcárcel J., Fernández-Santarén J., Ortín J. Degradation of cellular mRNA during influenza virus infection: Its possible role in protein synthesis shutoff. J. Gen. Virol. 73:1992;575-581.
56. Garfinkel M. S., Katze M. G. Translational control by influenza virus. Selective and cap-dependent translation of viral mRNAs in infected cells. J. Biol. Chem. 267:1992;9383-9390.
57. Garfinkel M. S., Katze M. G. Translational control by influenza virus. Selective translation is mediated by sequences within the viral mRNA 5′-untranslated region. J. Biol. Chem. 268:1993;22223-22226.
58. Enami K., Sato T. A., Nakada S., Enami M. Influenza virus NS1 protein stimulates translation of the M1 protein. J. Virol. 68:1994;1432-1437.
59. de la Luna S., Fortes P., Beloso A., Ortin J. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J. Virol. 69:1995;2427-2433.
60. Krug R. M., Etkind P. R. Cytoplasmic and nuclear specific proteins in influenza virus-infected MDCK cells. Virology. 56:1973;334-348.
61. Lazarowitz S. G., Compans R. W., Choppin P. W. Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology. 46:1971;830-843.
62. Park Y. W., Katze M. G. Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation. J. Biol. Chem. 270:1995;28433-28439.
63. Arrigo S. J., Chen I. S. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 5:1991;808-819.
64. D'Agostino D. M., Felber B. K., Harrison J. E., Pavlakis G. N. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol. Cell. Biol. 12:1992;1375-1386.
65. Campbell L. H., Borg K. T., Haines J. K., Moon R. T., Schoenberg D. R., Arrigo S. J. Human immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAs. J. Virol. 68:1994;5433-5438.
66. Hayes B. W., Telling G. C., Myat M. M., Williams J. F., Flint S. J. The Adenovirus L4 100-Kd protein is necessary for efficient translation of viral late mRNA species. J. Virol. 64:1990;2732-2742.
67. Riley D., Flint S. J. RNA-binding properties of a translational activator, the Adenovirus L4 100-Kd protein. J. Virol. 67:1993;3586-3595.
68. Wolff T., O'Neill R. E., Palese P. Interaction cloning of NS1-I, a human protein that binds to the nonstructural NS1 proteins of influenza A and B viruses. J. Virol. 70:1996;5363-5372.
69. St Johnston D., Beuchle D., Nusslein-Volhard C. Staufen, a gene required to localize maternal RNAs in the Drosophila egg. Cell. 66:1991;51-63.
70. Ruhl M., Himmelspach M., Bahr G. M., Hammerschmid F., Jaksche H., Wolff B., Aschauer H., Farrington G. K., Probst H., Bevec D., Hauber J. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J. Cell Biol. 123:1993;1309-1320.
71. Merrick W. C., Hershey J. W. B. The pathway and mechanism of eukaryotic protein synthesis. Hershey J. W. B., Mathews M. B., Sonenberg N. Translational Control. 1996;31-70 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
72. Jacobson A. Poly(A) metabolism and translation: The closed-loop model. Hershey J. W. B., Mathews M. B., Sonenberg N. Translational Control. 1996;451-480 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
73. Sachs A. B., Sarnow P., Hentze M. W. Starting at the beginning, middle and end: Translation initiation in eukaryotes. Cell. 89:1997;831-838.
74. Feigenblum D., Schneider R. J. Modification of eukaryotic initiation factor 4F during infection by influenza virus. J. Virol. 67:1993;3027-3035.
75. Koennecke I., Boschek C. B., Scholtissek C. Isolation and properties of a temperature-sensitive mutant (ts412) of the influenza virus recombinant with a lesion in the gene coding for the nonstructural protein. Virology. 110:1981;16-25.
76. Scholtissek C., Spring S. Extragenic suppression of temperature-sensitive mutations in RNA segment 8 by replacement of different RNA segments with those of other influenza A virus prototype strains. Virology. 118:1982;28-34.
77. Ludwig S., Vogel U., Scholtissek C. Amino acid replacements leading to temperature-sensitive defects of the NS1 protein of influenza A virus. Arch. Virol. 140:1995;945-950.
78. Hatada E., Takizawa T., Fukuda R. Specific binding of influenza A virus NS1 protein to the virus minus-sense RNA in vitro. J. Gen. Virol. 73:1992;17-25.
79. Marión R. M., Zürcher T., de la Luna S., Ortín J. Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. J. Gen. Virol. 78:1997;2447-2451.